Request information Product search
Altiora Peptide logoAltiora PeptideResearch peptide catalog

GLOW Peptide and Doping Tests: Understanding WADA Prohibited Status

BPC-157 and TB-500 are both on the 2026 WADA Prohibited List, so any blend containing them is banned for tested athletes. This article explains the WADA classifications and testing risk.

GLOW Peptide and Doping Tests: Understanding WADA Prohibited Status

WADA Prohibited List

For athletes, BPC-157 and TB-500 are both on the 2026 WADA Prohibited List. BPC-157 is listed under S0 as an unapproved substance, and TB-500 under S2 by name. GHK-Cu is not on the list.

A blend containing prohibited substances is a prohibited blend

GLOW contains BPC-157 and TB-500, so for tested athletes, GLOW is a prohibited blend. Whether or not GHK-Cu is banned, the blend’s overall status is determined by its prohibited components.

Testing risk

WADA testing can identify BPC-157 and TB-500. Because both peptides are named on the 2026 list, testing agencies screen for them. Athletes using GLOW face a risk of a positive test.

Difference between S0 and S2

S0 covers any substance not approved for human use. BPC-157 falls here because it has not been approved in any country. S2 covers peptide hormones, growth factors, and related substances. TB-500 is explicitly listed under S2.

Why this matters

For professional athletes, a positive test can lead to suspension, loss of results, and reputational damage. Understanding GLOW’s WADA status is a necessary step before using any peptide product.

Conclusion

GLOW contains two WADA-prohibited components, making it banned for tested athletes. Before considering any peptide product, athletes should consult the latest WADA Prohibited List.

WhatsApp